Latest Study In Genetics Of Miscarriage At Asia-Pacific Congress In Maternal Fetal Medicine (APCMFM 2024)
We are proud to announce that Dr. Nguyen Vu Khanh and Dr. Nguyen Son Tung from Gene Solutions attended and presented important findings in the genetics of miscarriage at the 17th APCMFM 2024. The study examined fetal or placental samples from miscarriages occurring under 24 weeks of gestation. Its purpose was to investigate the causes […]
Breast Cancer Awareness Month: Gene Solutions Indonesia and Garuda Sentra Medika Amplify Early Cancer Detection Education
This October, as the world turns its attention to breast cancer awareness, Gene Solutions Indonesia and Garuda Sentra Medika united to promote a powerful message: the importance of early cancer detection. On October 29, 2024, we hosted an inspiring event dedicated to empowering individuals with essential knowledge on early detection, particularly for breast cancer—one of […]
Gene Solutions Welcomes Evan Greger as Strategic Advisor to the Board of Directors
Gene Solutions, a pioneering genetic testing company in Asia, today announced the appointment of Evan Greger, M.Sc. and M.B.A., an experienced biotechnology and life sciences leader, as a Strategic Advisor to the Board of Directors. Evan brings nearly 30 years of diverse experience in the biotechnology and life sciences industry, enhancing our strategic vision and […]
Gene Solutions Thailand Exhibition & Symposium Highlight at TSCO Annual Meeting
Explore the highlights from our booth exhibition and symposium at the Thai Society of Clinical Oncology (TSCO) Annual Meeting, held from October 18-20, 2024, at Dusit Thani Pattaya, Thailand. During Symposium 3, Gene Solutions presented an insightful session featuring Professor Nick Pavlakis from the University of Sydney and Dr. Tu Ngoc Ly Lan from the […]
Gene Solutions Malaysia Partners with NCSM and MMA to “Break Barriers in Cancer”
Malacca, Malaysia – On October 19-20, 2024, Gene Solutions Malaysia joined the National Cancer Society Malaysia (NCSM) and the Malaysian Medical Association (MMA) for a significant roadshow in Malacca. With the theme “Breaking Barriers in Cancer: A Community Symposium,” this two-day event brought together the public and healthcare professionals (HCPs) to explore the latest insights […]
Announcement of Analytical Validation for SPOT-MAS on Five Cancers Lacking Standard Screening (LSS)
We previously developed a SPOT-MAS assay to capture ctDNA signatures from 05 common cancer types (breast, lung, liver, colorectal, and stomach) and successfully facilitated early-stage detection in both retrospective (1) and prospective validation (2) studies. The recent study published in Future Oncology, “Evaluation of a Multimodal ctDNA-Based Assay for Detection of Aggressive Cancers Lacking Standard […]
Gene Solutions’ Presentations at ASCOMOS 2024
Fueled by a mission to advance cancer care, Gene Solutions recently joined the 35th Annual Scientific Congress of the Malaysian Oncological Society (ASCOMOS 2024) as a Gold Sponsor. Held from October 11-13 at the Setia SPICE Convention Centre in Penang, the gathering brought together over 1,095 healthcare professionals who shared a collective passion for transforming […]
United for Early Detection at the IKN Pink October Carnival 2024!
On 5th October 2024, Gene Solutions Malaysia had the honor of participating in the IKN Pink October Carnival 2024, an event dedicated to raising awareness and fostering a sense of community around cancer prevention and early detection. This year’s theme, “Living Well, Living Together,” captured the essence of unity, strength, and awareness, reminding us all […]
Breaking Findings Reported in ESMO Real World Data and Digital Oncology Journal Reaffirm Clinical Validation of K-TRACK Circulating Tumor DNA in Patients with Resected Colorectal Cancer
A recent study published in the ESMO Real World Data and Digital Oncology journal has revealed the significant prognostic value of circulating tumor DNA (ctDNA) in predicting recurrence in colorectal cancer (CRC) patients. This publication combines clinical trial data with real-world evidence of the K-TRACK assay from Gene Solutions, offering compelling insights for oncologists and surgeons […]
Gene Solutions Establishes Global Market Footprint with Pioneering MCED and MRD Tests in CAP-Accredited Laboratory
Gene Solutions Group proudly announces that our Next-Generation Sequencing laboratory in Singapore has been awarded College of American Pathologists (CAP) accreditation. This honor, granted after a rigorous on-site evaluation, provides recognition of the clinical utility of our circulating tumor DNA (ctDNA) tests, specifically in Multi-Cancer Early Detection (MCED) and Minimal Residual Disease (MRD) monitoring. These […]